Why Size and Shape do matter.

In April 2020, Yokogawa announced the acquisition of the US company Fluid Imaging Technologies Inc (YFT). This article will briefly introduce the FlowCam products and their strategic relevance for the Yokogawa Life Innovation Business.

Puntasit Choksawatdikorn

Yokogawa Fluid Imaging Technology is striving for a bigger footprint

Yokogawa Fluid Imaging TechnologiesOn April 16th, 2020 Yokogawa announced the acquisition of Fluid Imaging Technologies, Inc., a US-based company. Fluid Imaging Technologies Inc. specialized in the development, manufacturing, and analysis of particles in liquids. The now called Yokogawa Fluid Imaging Technology (YFT) products will be part of and extend the portfolio offering of the Yokogawa Life Innovation Business (LIB).

What is so special about the YFT products?

The FlowCam product portfolio combines the features of traditional microscopes, which are used for the observation of adherent cells, and flow cytometers, which are used for high-speed analysis of the characteristics of suspension cells like lymph and other types of blood cells. FlowCam instruments rapidly count and image particles in a fluid stream. The VisualSpreadsheet software functions measures, sorts, analyzes, and counts those particle images. With that, the FlowCam instruments can be used in fields such as marine research and municipal water management as well as industries ranging from biopharmaceuticals to chemicals.

Why is it important to have the YFT products in the LIB portfolio?

For decades Yokogawa develops state-of-the-art products for the observation of living cells. One of the main innovations – our microlens enhanced dual spinning disk technology is widely used in Confocal Spinning Units (CSU) to equip confocal microscopes for basic research to drug development applications. This proprietary imaging technology is also incorporated in the Yokogawa High Content Imaging (HCI) products of the CellVoyager family. All these imaging platforms are mainly used to observe living 2D, 3D or 4D cultures of adherent cells. With the new FlowCam products for particles respectively cells in solution, Yokogawa will expand its portfolio of cell observation solutions offered by the Life Innovation Business strengthening its business targeting in the bioeconomy market.

YFT FlowCam + LO
FlowCam + LO

Over the remaining years, the FlowCam has significantly expanded its market share. Known and very well respected already in the world of aquatic-related scientists, industrial customers became more and more convinced. The FlowCam offers superior picture quality combined with a modular design offering very high flexibility to be configured for customer needs. Different magnifications from 20x to 2x are available, even 40x is given with the FlowCam Nano. One of its kind is the optional use of a laser to analyze at the same time morphological properties of the particles, respectively cells in a sample, same as the fluorescence signal.  Last but not least, the FlowCam LO,  was introduced. It combines the technique of dynamic picture analyzes with the light obscuration in one instrument.  Our ambitious goals for YFT? Taking the leading edge today and in the future to offer the customer the best solutions available.

Is Yokogawa expecting a hard transition and rough start?

With the acquisition of Fluid Imaging Technologies, Yokogawa was fortunate to partner with an already very successful company having established sales channels, a solid customer base, and a strongly growing market presence. In continental Europe, Yokogawa will continue the sale of the YFT products through our long-time and trusted distribution partner ANASYSTA e.K. For close to 14 years ANASYSTA supports the development, sale, and servicing of FlowCam products in Europe. Our existing and new customers can expect the same service and support level they are familiar with. We also expect that Yokogawa can contribute business contacts from our other core business to promote the FlowCam portfolio to new interested stakeholders. Yokogawa and the YFT business represented by ANASYSTA believe there are many synergies in the existing customer base that can benefit from each-others offerings. The first steps to better and closer collaboration are already on their way.

The Yokogawa LIB Europe, the YFT global team, and ANASYSTA are much looking forward to the first mutual business steps in the European market.

Are you curious about our YFT products in detail? Looking for use cases? Then check out our website and stay tuned for our Flowcam introduction series. Curtain up! 

Axel Wilde

Owner of ANASYSTA

  • Share

  • Tweet

  • Post

More

You may also like

GENOMICS / April 15, 2021

“I like the combination of my scientific background with business aspects”

Dr. Erika Zernickel joined Yokogawa in February 2021. In this blog, she gives an interview about herself and her role in the Life Innovation Business team. Welcome to the exciting world of LIB, Erika!

Read more

LIFE SCIENCE GENERAL / April 14, 2021

Wanted: Field Service Engineer (f/m/n)

Do you want to join our team? We are looking for a dedicated Field Service Engineer (f/m/n).

Read more

DRUG DISCOVERY / April 13, 2021

Single-Cell Analysis: All cells are created equal, but are they?

The Yokogawa Life Innovation Business recently developed in-house and through the acquisition of BioStinger Inc. new solutions for Single Cell Analysis (SCA). Today we would like to briefly introduce two new SCA research solutions.

Read more

Write a comment


Did you like the blog article? Do you have any suggestions, questions, criticism? Discuss them with us here. We look forward to your comments.